Cargando…
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
BACKGROUND: Endometrial cancer is the most common gynecologic malignancy, and its incidence and associated mortality are increasing. Despite the immediate need to detect these cancers at an earlier stage, there is no effective screening methodology or protocol for endometrial cancer. The comprehensi...
Autores principales: | Nair, Navya, Camacho-Vanegas, Olga, Rykunov, Dmitry, Dashkoff, Matthew, Camacho, Sandra Catalina, Schumacher, Cassie A., Irish, Jonathan C., Harkins, Timothy T., Freeman, Elijah, Garcia, Isaac, Pereira, Elena, Kendall, Sviatoslav, Belfer, Rachel, Kalir, Tamara, Sebra, Robert, Reva, Boris, Dottino, Peter, Martignetti, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189938/ https://www.ncbi.nlm.nih.gov/pubmed/28027320 http://dx.doi.org/10.1371/journal.pmed.1002206 |
Ejemplares similares
-
Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a “Molecular Second Look”
por: Schwartz, Melissa, et al.
Publicado: (2018) -
Rapid development and use of patient-specific ctDNA biomarkers to avoid a “rash decision” in an ovarian cancer patient
por: Pandya, Deep, et al.
Publicado: (2019) -
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
por: Agnani, Deep, et al.
Publicado: (2011) -
Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy
por: Martignetti, John A., et al.
Publicado: (2018) -
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
por: Pereira, Elena, et al.
Publicado: (2015)